Kennedy's disease 1234 scale: Preliminary design and test
Ming Lu1, Haixiao Guo2, Dongsheng Fan1
1Department of Neurology, Peking University Third Hospital, Beijing, China.
Summary
A new scale, KD 1234, accurately measures changes in Kennedy's disease (spinal and bulbar muscular atrophy) patients. This scale is more suitable for clinical studies than the previously used ALSFRS scale.
Area of Science:
- Neurology
- Genetics
- Clinical Assessment
Background:
- Kennedy's disease (KD), or spinal and bulbar muscular atrophy (SBMA), is a rare X-linked genetic disorder causing muscle weakness and atrophy.
- The ALSFRS scale, designed for ALS, is not sensitive enough to track the slow progression of KD.
- A validated, KD-specific scale is needed for accurate clinical assessment and research.
Purpose of the Study:
- To develop and validate a new scale, KD 1234, specifically designed for assessing Kennedy's disease patients.
- To compare the efficacy of the KD 1234 scale against the ALSFRS scale in KD patients.
- To establish the reliability and validity of the KD 1234 scale for clinical use.
Main Methods:
- Developed the KD 1234 scale tailored for Kennedy's disease.
- Evaluated the KD 1234 scale and ALSFRS in 81 KD patients and 100 healthy controls.
- Assessed scale reliability (inter-rater, split-half, internal consistency) and validity (content, structure).
- Conducted longitudinal analysis on 52 KD patients over 32 months.
Main Results:
- The KD 1234 scale demonstrated simplicity and ease of operation.
- The scale exhibited good reliability, validity, and reactivity in assessing KD patients.
- Longitudinal data confirmed the scale's ability to track changes over time.
Conclusions:
- The KD 1234 scale is a reliable and valid tool for quantitatively evaluating the clinical status of Kennedy's disease patients.
- This specialized scale is suitable for use in clinical studies to monitor disease progression.
- The KD 1234 scale offers an improvement over the ALSFRS for KD patient assessment.
